title: The effects of care management on depression treatment in a psychiatric clinic: a randomized controlled trial.
abstract: OBJECTIVE
  This study aims to examine whether care management has an effect on adherence to depression treatment in a psychiatric clinic in Korea.
  
  
  METHODS
  Fifty-seven patients with depression aged 60 years or over participated in the study. They were all low-income patients screened in the community and treated in a psychiatric clinic. The study design was a double-blind randomized controlled trial. The patients were randomly assigned to intervention (n = 29) or usual care (n = 28) groups. Intervention patients received depression care management for 6 months. Primary endpoint was an increase in remission rate as assessed using the 17-item Hamilton Depression Rating Scale score at 6 months. Secondary endpoints included improvement in treatment adherence, improvement in health-related quality of life, and a reduction in feelings of hopelessness.
  
  
  RESULTS
  Patients in the care management intervention group showed a higher remission rate than those in the usual care group (55% vs. 29%, p = 0.0421). Intervention patients were significantly more likely to adhere to the treatment (59% vs. 18%, p = 0.0016). The hopelessness score at the 6-month assessment was significantly lower in the intervention group than the usual care group (23.5 vs. 25.7, p = 0.0443). However, there was not a significant group difference in the quality of life.
  
  
  CONCLUSIONS
  We found that care management not only contributed to reducing depressive symptoms in geriatric patients suffering from depression but also increased the treatment adherence rate, which in turn increased the remission rate. Care management intervention is both feasible and effective in psychiatric clinics in Korea.
authors.affiliation: Department of Preventive Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea; Clinical Research Center for Depression, Seoul, Korea.
authors.forename: Hyunsuk
authors.initials: H
authors.lastname: Jeong
authors.forename: Hyeon Woo
authors.initials: HW
authors.lastname: Yim
authors.forename: Sun-jin
authors.initials: SJ
authors.lastname: Jo
authors.forename: Beomwoo
authors.initials: B
authors.lastname: Nam
authors.forename: Soon-Mo
authors.initials: SM
authors.lastname: Kwon
authors.forename: Jin-Yong
authors.initials: JY
authors.lastname: Choi
authors.forename: Sang-Kuk
authors.initials: SK
authors.lastname: Yang
mesh_terms: D000368:Aged; D000928:Antidepressive Agents / Q000627:therapeutic use; D003866:Depressive Disorder / Q000628:therapy*; D004311:Double-Blind Method; D005260:Female; D006304:Health Status; D006778:Hospitals, Psychiatric; D006801:Humans; D008297:Male; D008875:Middle Aged; D010346:Patient Care Management; D010349:Patient Compliance; D011569:Psychiatric Status Rating Scales; D011613:Psychotherapy / Q000379:methods; D011788:Quality of Life; D056910:Republic of Korea
chemical_list: D000928:Antidepressive Agents